```

[Federal Register Volume 90, Number 22 (Tuesday, February 4, 2025)]
[Notices]
[Page 8943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-02186]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on January 6, 2025, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology 
Enterprise Consortium (``MTEC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, AccelerMED LLC, Shoreview, MN; Aegir 
Enterprises LLC, Jamul, CA; ANT5 Co., Ltd., Ube, JAPAN; ARNAV Biotech, 
Atlanta, GA; Artery Studios, Inc., Toronto, CANADA; Astrapi Corp., 
Dallas, TX; Athena Consulting Group LLC, North Charleston, SC; Auxilium 
Health, Inc., Cleveland, OH; Berkeley Fit LLC, San Diego, CA; Circuit 
Design Specialties, Inc., Plano, TX; Clinical Research Strategies LLC, 
Wexford, PA; Curavit Clinical Research, Scarsdale, NY; DatavizVR, Inc. 
dba 3Data, Austin, TX; DesignPlex Biomedical LLC, Fort Worth, TX; ECS 
Federal LLC, Fairfax, VA; Evimero LLC, Tuscaloosa, AL; Exsurgo 
Technologies LLC, Ashburn, VA; Functional Longevity Labs, Inc., Easton, 
MD; Green Immune LLC, Columbus, GA; HereNow Help, Inc., Honeoye, NY; 
Hermtac LLC, Dallas, TX; ICON Government and Public Health Solutions, 
Inc., Blue Bell, PA; InflammaSense, Inc., Carlsbad, CA; Institute for 
Evolvable Medicines, Oakland, CA; Jaunt LLC, Mesa, AZ; Key 
Technologies, Inc., Baltimore, MD; Machina Medical, Inc., Roswell, GA; 
Microbion Corp., Bozeman, MT; NCS Technologies, Inc., Manassas, VA; 
Neolixir, Ltd., Nedlands, AUSTRALIA; NeuEsse, Inc., Dunbar, PA; 
Physical Sciences, Inc., Andover, MA; POP Biotechnologies, Inc., 
Buffalo, NY; Qumulo, Inc., Seattle, WA; SightLine Ventures, Dayton, OH; 
Songhi Innovations, Fountain, CO; Teleflex, Inc., Morrisville, NC; 
Texas Biomedical Research Institute, San Antonio, TX; The Neutrino 
Donut LLC, Culver City, CA; University of Tennessee, Knoxville, TN; 
University of Utah, Salt Lake City, UT; Varada Consulting LLC, Vienna, 
VA; and Zeteo Tech, Inc., Sykesville, MD have been added as parties to 
this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to section 6(b) of the Act on June 9, 
2014(79 FR 32999).
    The last notification was filed with the Department on October 7, 
2024. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act on December 20, 2024 (89 FR 104210).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2025-02186 Filed 2-3-25; 8:45 am]
BILLING CODE P
```